K. Eristavi National Center of Experimental and Clinical Surgery (სს კ. ერისთავის სახელობის ექსპერიმენტული და კლინიკური ქირურგიის ეროვნული ცენტრი) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

K. Eristavi National Center of Experimental and Clinical Surgery (სს კ. ერისთავის სახელობის ექსპერიმენტული და კლინიკური ქირურგიის ეროვნული ცენტრი) — Georgia Financials

as filed · GEL, thousands

Line item	2017	2018	2019	2020	2021	2022	2023	2024	CAGR
Total Revenue	31,673	35,771	41,848	40,982	53,361	46,143	50,871	56,342	+8.6%
	6,203	6,644	7,958	8,298	10,841	9,458	9,346	10,326	+7.6%
Gross Profit	25,471	29,127	33,890	32,683	42,521	36,685	41,526	46,016	+8.8%
Gross Margin	80.4%	81.4%	81.0%	79.8%	79.7%	79.5%	81.6%	81.7%
Other Operating Income	0	0	139	138	228	294	529	510	+29.8%
	3,949	18,427	21,614	19,793	25,857	26,497	31,072	32,872	+35.4%
EBITDA	21,522	10,699	12,415	13,029	16,891	10,483	10,982	13,653	-6.3%
EBITDA Margin	68.0%	29.9%	29.7%	31.8%	31.7%	22.7%	21.6%	24.2%
Total D&A	2,134	4,226	5,379	5,746	6,658	7,634	7,663	9,390	+23.6%
EBIT / Operating Income	19,388	6,474	7,036	7,282	10,232	2,849	3,319	4,263	-19.5%
Total Interest Income	235	175	138	300	298	423	265	273	+2.1%
Total Interest Expense	237	490	491	441	349	175	278	1,268	+27.1%
Total Other Income	0	0	791	2,790	1,420	1,067	640	510	nmf
Profit Before Tax	19,386	6,159	5,893	4,351	11,601	4,163	2,666	3,778	-20.8%
Total Income Tax	0	0	0	0	0	0	0	0
Net Profit / (Loss)	6,495	6,159	5,893	4,351	11,601	4,163	2,666	3,778	-7.4%
Net Margin	20.5%	17.2%	14.1%	10.6%	21.7%	9.0%	5.2%	6.7%